Ten years ago, Sajith Wickramasekara dropped out of the Computer Science program at MIT to build something new: a software company that helps life science researchers better organize their lab work.
On Thursday, San Francisco-based R&D cloud software company Benchling announced that it has acquired Belfast-based Ovewatch Research, a software company for customers working on preclinical biopharma ...
Sajith Wickramasekara, Benchling’s CEO and co-founder. Eight months after enabling its R&D cloud to support FDA-regulated work done in later stages of biopharma product development, Benchling has ...
After collecting $300 million across two venture capital rounds last year, R&D cloud software developer Benchling is starting to spend some of that cash by making its first acquisition. The company ...
Investors are eager for the Benchling IPO. The company made headlines when it confidentially filed with the SEC to go public. Biotechnology is rewriting life as we know it. Our customers, spanning ...
Benchling is a next-gen laboratory informatics platform that is helping life science companies manage increasingly complex data workflows. GEN Edge talks to CEO/co-founder Saji Wickramasekara and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results